CCAL
ADMA icon

City Center Advisors LLC’s ADMA Biologics ADMA Stock Holding History

City Center Advisors LLC’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$377K Buy
+37,628
New +$348K 0.29% 98
2026
Q1 		– Sell
-22,917
Closed -$418K – 156
2025
Q4 		$418K Buy
+22,917
New +$386K 0.38% 80
2025
Q3 		– Sell
-10,597
Closed -$193K – 165
2025
Q2 		$193K Buy
+10,597
New +$216K 0.21% 160

Other funds holding ADMA

NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

City Center Advisors LLC's ADMA Position: Q3 2026 in Review

City Center Advisors LLC opened a new position in ADMA Biologics (ADMA) in Q3 2026: 37,628 shares worth $377K. The stake represents 0.29% of the portfolio and ranks #98 among its holdings. This is a return to the name: City Center Advisors LLC previously reported a position in ADMA as recently as Q4 2025.

City Center Advisors LLC first reported a position in ADMA in Q2 2025 and has held it in 3 quarters since. The position peaked at $418K in Q4 2025. 12 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • City Center Advisors LLC held 37,628 shares of ADMA Biologics worth $377K as of Q3 2026.
  • ADMA Biologics was a new City Center Advisors LLC position in Q3 2026.
  • ADMA Biologics made up 0.29% of City Center Advisors LLC's portfolio in Q3 2026, its #98 holding.
  • City Center Advisors LLC first reported a position in ADMA Biologics in Q2 2025 and has held it in 3 quarters since.
  • City Center Advisors LLC's ADMA Biologics position peaked at $418K in Q4 2025.
  • 12 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on City Center Advisors LLC's 13F filing for Q3 2026, filed 8 Oct 2026.